Nav: Home

Bioscience initiative speeds new technologies to consumers

April 15, 2016

STORRS, CT -- an artificial salivary gland and a light imaging system that detects ovarian cancer faster are two UConn-faculty designed projects that will receive funding from a $1 million Connecticut Innovations program designed to encourage the creation of biomedical devices from Connecticut universities and colleges.

The BioScience Pipeline Program is a joint venture between Connecticut Innovations, UConn, Yale and Quinnipiac University. The deadline for the next two rounds of applications are April 22 and October 7. Other higher education institutions are encouraged to apply, and collaborations between multiple universities and colleges are encouraged.

"This program has two benefits- creating new health technologies that benefit consumers, and creating innovative start-up companies that benefit the economy of Connecticut," said Hadi Bozorgmanesh, co-executive director of the UConn School of Engineering Entrepreneurship and Innovation Consortium.

The Engineering Entrepreneurship and Innovation Consortium fosters business ventures created by UConn faculty and students.

At UConn Mei Wei, associate dean for research in the school of engineering, is creating a bone scaffold system that could replace some bone grafts and cause injuries to heal faster; Quing Zhu of the biomedical engineering department is developing a miniaturized light imaging system for rapid detection of ovarian cancer; Robert Kelly in reconstructive sciences is creating an artificial salivary gland to alleviate dry mouth; and Guoan Zheng and Kazunori Hoshino are making a new, cost-effective whole slide imaging kit that allows medical professionals to view a digital image of the entire section of stained tissues, which will streamline the workflow of cancer diagnosis.

Connecticut Innovations is the leading source of financing and ongoing support for the state's innovative, growing companies.

University of Connecticut School of Engineering

Related Ovarian Cancer Articles:

Uncovering the mechanisms that support the spread of ovarian cancer
In this issue of the JCI, research led by Wang Min at Yale University describes how a subtype of macrophages communicate with and support tumor cell growth to drive metastasis in ovarian cancer.
Ovarian cancer study uncovers new biology
In what is believed to be the largest study of its kind, scientists at The Johns Hopkins University and the Pacific Northwest National Laboratory led a study that examined the proteomes of 169 ovarian cancer patients to identify critical proteins expressed by their tumors.
Chemotherapy may boost immunotherapy power in ovarian cancer
Cancer Research UK scientists have found that women with advanced ovarian cancer may benefit more from immunotherapy drug treatments if they are given straight after chemotherapy.
UA engineers zero in on early detection of ovarian cancer
University of Arizona researcher Jennifer Barton is leading a two-year, $1 million project funded by the National Cancer Institute to identify imaging biomarkers of ovarian cancer, the most deadly gynecological cancer in the United States.
Ludwig Cancer Research and CRI initiate clinical trial of immunotherapy for ovarian cancer
Ludwig Cancer Research and the Cancer Research Institute (CRI) have launched a Phase 1/2 clinical trial of combination immunotherapy for advanced ovarian cancer.
Different types of ovarian cancer have different causes
The more children a woman has or whether a woman has had her fallopian tubes cut lowers the risk of different types of ovarian cancer to different levels, according to new research presented at the 2015 National Cancer Research Institute Cancer Conference Tuesday.
Researchers isolate possible ovarian cancer biomarkers
Researchers from North Carolina State University utilized a highly sensitive mass spectrometry analysis to identify and measure difficult-to-detect N-glycan biomarkers associated with ovarian cancers in stages I-IV.
New Stand Up To Cancer-OCRF-OCNA-NOCC Ovarian Cancer Dream Team announced
The Stand Up To Cancer, Ovarian Cancer Research Fund, Ovarian Cancer National Alliance, and National Ovarian Cancer Coalition $6 milion Ovarian Cancer Dream Team will focus on DNA repair pathways and therapies for ovarian cancer, seeking to expand on the recent clinical advances seen with PARP inhibitors.
Seeking new targets for ovarian cancer treatment
Identifying molecular changes that occur in tissue after chemotherapy could be crucial in advancing treatments for ovarian cancer, according to research from Magee-Womens Research Institute and Foundation and the University of Pittsburgh Cancer Institute presented today at the American Association for Cancer Research Annual Meeting 2015.
'Patchwork' ovarian cancer more deadly
The most common type of ovarian cancer is more deadly if it consists of a patchwork of different groups of cells, according to a Cancer Research UK study published today in PLOS Medicine.

Related Ovarian Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".